SQZ Biotech Garners $16,000,000 Series B Funding

  • Feed Type
  • Date
    9/30/2016
  • Company Name
    SQZ Biotech
  • Mailing Address
    100 Morrissey Blvd. Boston, MA 02125 USA
  • Company Description
    Many promising therapeutic modalities have limited clinical efficacy due to the challenges of delivering molecules into cells. SQZ Biotech seeks to address this fundamental problem by developing its CellSqueeze platform for use in drug discovery and clinical applications.
  • Website
    http://www.sqzbiotech.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    SQZ will utilize the funds to advance its preclinical immuno-therapy programs in oncology and other serious diseases.
  • M&A Terms
  • Venture Investor
    NanoDimension
  • Venture Investor
    Polaris Partners
  • Venture Investor
    Undisclosed

Trending on Xconomy